Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 8/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.42 |
| ▸ | HPGD | P15428 | 7/20 | 0.42 |
| ▸ | MAPT | P10636 | 6/20 | 0.42 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26300188 | 0.84 | ADORA3 (0.46) | ALDH1A1HPGDKDM4ELMNAADORA1 | |
| SCHEMBL24840280 | 0.80 | ALDH1A1 (0.46) | MEN1KMT2AALDH1A1HPGDMAPT | |
| SCHEMBL27097955 | 0.78 | MEN1 (0.42) | MEN1KMT2AALDH1A1HPGDMAPT | |
| SCHEMBL14425595 | 0.76 | MEN1 (0.68) | MEN1KMT2AALDH1A1HPGDMAPT | |
| SCHEMBL14425935 | 0.76 | MEN1 (0.68) | MEN1KMT2AALDH1A1HPGDMAPT | |
| SCHEMBL14425939 | 0.76 | MEN1 (0.68) | MEN1KMT2AALDH1A1HPGDMAPT | |
| SCHEMBL14425570 | 0.76 | MEN1 (0.68) | MEN1KMT2AALDH1A1HPGDMAPT | |
| SCHEMBL15458332 | 0.76 | MEN1 (0.68) | MEN1KMT2AALDH1A1HPGDMAPT | |
| SCHEMBL22186231 | 0.76 | MEN1 (0.68) | MEN1KMT2AALDH1A1HPGDMAPT | |
| SCHEMBL24767679 | 0.76 | MEN1 (0.68) | MEN1KMT2AALDH1A1HPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11912712-B2 | Organic electroluminescent element having an organic compound | BEIJING BAYI SPACE LIQUID CRYSTAL TECHNOLOGY CO. LTD. (CN) | 2024-02-27 | — | — | US | disclosed |
| US-11912712-B2 | Organic electroluminescent element having an organic compound | BEIJING BAYI SPACE LIQUID CRYSTAL TECHNOLOGY CO. LTD. (CN) | 2024-02-27 | — | — | US | disclosed |
| US-20230286992-A1 | ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC ELECTROLUMINESCENT ELEMENT | BEIJING BAYI SPACE LIQUID CRYSTAL TECHNOLOGY CO. LTD. (CN) | 2023-09-14 | — | — | US | disclosed |
| US-20230286992-A1 | ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC ELECTROLUMINESCENT ELEMENT | BEIJING BAYI SPACE LIQUID CRYSTAL TECHNOLOGY CO. LTD. (CN) | 2023-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230286992-A1 | ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC ELECTROLUMINESCENT ELEMENT | SLCO4C1, SLCO1A2, SLCO2A1 | MEN1 3047/4885KMT2A 2211/4885ALDH1A1 313/4885 |
| US-11912712-B2 | Organic electroluminescent element having an organic compound | SLCO4C1, SLCO1A2, SLCO2A1 | MEN1 3102/4885KMT2A 2138/4885ALDH1A1 485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.